PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Megestrol acetate
Presentation Product Chemical substance Chapter Items dispensed
Megestrol 160mg tablets
0803020L0AAABAB
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression 1,337
Megace 160mg tablets
0803020L0BBACAB
Megace Megestrol acetate Malignant Disease and Immunosuppression 460
Megestrol 40mg tablets
0803020L0AAAAAA
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression 87
Megestrol 160mg/5ml oral suspension
0803020L0AAACAC
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression 2
Megace 40mg tablets
0803020L0BBAAAA
Megace Megestrol acetate Malignant Disease and Immunosuppression No data available
Megestrol 10mg/5ml oral suspension
0803020L0AAAFAF
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression No data available
Megestrol 200mg/5ml oral suspension
0803020L0AAAGAG
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression No data available
Megestrol 20mg capsules
0803020L0AAAJAJ
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression No data available
Megestrol 20mg/5ml oral suspension
0803020L0AAAEAE
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression No data available
Megestrol 40mg/5ml oral suspension
0803020L0AAAHAH
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression No data available
Megestrol 50mg capsules
0803020L0AAAIAI
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression No data available
Megestrol 80mg tablets
0803020L0AAAKAK
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression No data available
Megestrol 80mg/5ml oral suspension
0803020L0AAADAD
Megestrol acetate Megestrol acetate Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.